Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Abbott Laboratories (ABT) had Cost of Goods Sold of $5.33B for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$12.59B |
|
$928.00M |
|
|
Cost of Goods Sold |
$5.33B |
$7.27B |
|
$10.90B |
|
$1.69B |
|
$-169.00M |
|
$1.52B |
|
$1.52B |
|
$928.00M |
|
$928.00M |
|
$928.00M |
|
$928.00M |
|
$1.69B |
|
-- |
|
-- |
|
1.74B |
|
-- |
|
$0.53 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|